CD3+/CD8+ T-cell density and tumoral PD-L1 predict survival irrespective of rituximab treatment in Chinese diffuse large B-cell lymphoma patients. [electronic resource]
Producer: 20181106Description: 254-266 p. digitalISSN:- 1865-3774
- Adult
- Aged
- Aged, 80 and over
- Asian People
- B7-H1 Antigen -- genetics
- CD3 Complex
- CD8-Positive T-Lymphocytes -- pathology
- Female
- Forecasting
- Gene Expression
- Humans
- Immunohistochemistry
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Prognosis
- Rituximab -- therapeutic use
- Survival
- T-Lymphocytes -- pathology
- Tumor Microenvironment -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.